El Hospital Clínico Universitario Virgen de la Arrixaca, es un complejo hospitalario público de Murcia, situado en la Avenida del Primero de Mayo, S/N, en la pedanía murciana de El Palmar. En la actualidad, se trata del mayor complejo hospitalario del Sistema Sanitario Público de Murcia.

During the past decade, Hospital Universitario Virgen de la Arrixaca conducted 274 clinical trials. In the 10-year time frame, 274 clinical trials started and 62 clinical trials were completed, i.e. on average, 22.6% percent of trials that started reached the finish line to date. In the past 5 years, 139 clinical trials started and 47 clinical trials were completed. i.e. 33.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Virgen de la Arrixaca" #1 sponsor was "Hoffmann-La Roche" with 27 trials, followed by "PETHEMA Foundation" with 16 trials sponsored, "Pfizer" with 15 trials sponsored, "Spanish Breast Cancer Research Group" with 15 trials sponsored and "Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia" with 15 trials sponsored. Other sponsors include 288 different institutions and companies that sponsored additional 185 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen de la Arrixaca" #1 collaborator was "Hospital Universitario Virgen de la Arrixaca" with 12 trials as a collaborator, "Instituto de Salud Carlos III" with 10 trials as a collaborator, "Hoffmann-La Roche" with 8 trials as a collaborator, "Pfizer" with 7 trials as a collaborator and "AstraZeneca" with 5 trials as a collaborator. Other collaborators include 260 different institutions and companies that were collaborators in the rest 196 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen de la Arrixaca" are "Coronary Artery Disease" (20 trials), "Breast Cancer" (18 trials), "Heart Failure" (12 trials), "Cystic Fibrosis" (10 trials) and "Multiple Myeloma" (10 trials). Many other conditions were trialed in "Hospital Universitario Virgen de la Arrixaca" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Virgen de la Arrixaca" are "Drug" (231 trials), "Device" (38 trials), "Procedure" (33 trials), "Other" (31 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Paclitaxel" (14 trials), "Cyclophosphamide" (11 trials), "Dexamethasone" (10 trials) and "ELX/TEZ/IVA" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Virgen de la Arrixaca" are 328 trials for "All" genders, 42 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 155 active trials in "Hospital Universitario Virgen de la Arrixaca". 2 are not yet recruiting, 105 are recruiting, 45 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 161 completed trials in Hospital Universitario Virgen de la Arrixaca, 1 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Virgen de la Arrixaca, 22 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 133 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 32 trials, and there were also 41 trials that are defined as “Not Applicable".